Variations in intake of tamsulosin.
Chadha
Vikas
V
Borooah
Shyamanga
S
D058668:Adrenergic alpha-1 Receptor Antagonists; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D011307:Drug Prescriptions / Q000706:statistics & numerical data*; D004363:Drug Utilization / Q000706:statistics & numerical data; D006801:Humans; D007431:Intraoperative Complications; D007499:Iris Diseases / Q000139:chemically induced / Q000453:epidemiology; D019654:Lens Implantation, Intraocular; D008297:Male; D018918:Phacoemulsification; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D015995:Prevalence; D011470:Prostatic Hyperplasia / Q000188:drug therapy / Q000453:epidemiology*; D011680:Pupil / Q000187:drug effects; D013449:Sulfonamides / Q000009:adverse effects / Q000627:therapeutic use*; D000077409:Tamsulosin; D006113:United Kingdom / Q000453:epidemiology; D014481:United States / Q000453:epidemiology
D058668:Adrenergic alpha-1 Receptor Antagonists; D000970:Antineoplastic Agents; D013449:Sulfonamides; D000077409:Tamsulosin